Logo-npj
Submitted: 25 Jul 2022
Accepted: 18 Sep 2022
ePublished: 22 Nov 2022
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

J Nephropharmacol. 2023;12(1): e10519.
doi: 10.34172/npj.2022.10519
  Abstract View: 4561
  PDF Download: 1243

Review

Recurrence of rare disease after kidney transplant

Farahnoosh Farnood ORCID logo, Seyyedeh Mina Hejazian ORCID logo, Kamal Boostani ORCID logo, Alireza Mardomi ORCID logo, Mohammadreza Ardalan* ORCID logo

1 Kidney Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
*Corresponding Author: Corresponding author: Prof. Mohammadreza Ardalan, Email: ardalan34@yahoo.com, , Email: ardalanm@tbzmed.ac.ir

Abstract

The incidence of chronic kidney diseases (CKDs) by rare etiologies is growing along with other CKDs. This mini-review discusses the epidemiology, pathogenesis, clinical presentation, and diagnosis of rare kidney disease recurrence after kidney transplantation (KTx) including primary hyperoxaluria (PH), adenine phosphoribosyl transferase (APRT), C3 glomerulopathy (C3 GP), and fibrillary glomerulonephritis (FGN). It was shown that PH, like acute rejection, causes delayed graft function, confusing the physicians. Moreover, C3 GP is more prevalent than FGN among kidney transplant patients. Therefore, it is necessary to monitor rare diseases (RDs) before KTx in patients with any history of bilateral nephrocalcinosis or nephrolithiasis.

Implication for health policy/practice/research/medical education:

Although kidney transplantation (KTx) is the standard gold therapy for end-stage renal disease (ESRD), this treatment is not a definitive and complete approach for kinds of rare chronic kidney disease (CKD) such as primary hyperoxaluria (PH), adenine phosphoribosyl transferase (APRT), C3 glomerulopathy (C3 GP), and fibrillary glomerulonephritis (FGN). These diseases frequently recur after kidney transplant, expect FGN mimic acute rejection. For this reason, monitoring of such rare diseases is necessary before KTx, especially in patients with any history of bilateral nephrocalcinosis or nephrolithiasis.

Please cite this paper as: Farnood F, Hejazian SM, Boostani K, Mardomi A, Ardalan M. Recurrence of rare disease after kidney transplant. J Nephropharmacol. 2023;12(1):e10519. DOI: 10.34172/npj.2022.10519.

First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 4562

Your browser does not support the canvas element.


PDF Download: 1243

Your browser does not support the canvas element.